Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention.
- DOI
- 10.1016/j.mcn.2025.104037
- Published
- 2025 Dec
- Container
- Molecular and cellular neurosciences
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.mcn.2025.104037,
title = {Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention.},
author = {Mohan D and Venkatesan R and Kandy AT and Muthu S and Jayaram S and Baskaran R and Pethappachetty P and Selvaraj D},
year = {2025},
journal = {Molecular and cellular neurosciences},
doi = {10.1016/j.mcn.2025.104037},
url = {https://doi.org/10.1016/j.mcn.2025.104037}
}RIS
TY - JOUR TI - Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention. AU - Mohan D AU - Venkatesan R AU - Kandy AT AU - Muthu S AU - Jayaram S AU - Baskaran R AU - Pethappachetty P AU - Selvaraj D PY - 2025 JO - Molecular and cellular neurosciences DO - 10.1016/j.mcn.2025.104037 UR - https://doi.org/10.1016/j.mcn.2025.104037 ER -
APA
D, M., R, V., AT, K., S, M., S, J., R, B., P, P., & D, S. (2025). Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention.. Molecular and cellular neurosciences. https://doi.org/10.1016/j.mcn.2025.104037
Source records
- pubmed · retrieved 2026-09-26T22:56:53.244Z
- europe-pmc · retrieved 2026-09-26T22:56:53.274Z